Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Suppression of Proinflammatory Cytokine Expression by Herpes Simplex Virus Type 1Journal of Virology, 2004
- Formation of High Affinity C5 Convertase of the Classical Pathway of ComplementJournal of Biological Chemistry, 2003
- Antibody neutralization and escape by HIV-1Nature, 2003
- Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Open Reading Frame 4 Protein (Kaposica) Is a Functional Homolog of Complement Control ProteinsJournal of Virology, 2003
- HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sitesNature, 2002
- Critical Role of Complement and Viral Evasion of Complement in Acute, Persistent, and Latent γ-Herpesvirus InfectionImmunity, 2002
- Immunologic Strategies for Herpes VaccinationJAMA, 2000
- Herpes Simplex Virus Glycoprotein C is a Receptor for Complement Component iC3bThe Journal of Infectious Diseases, 1991
- Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.Journal of Experimental Medicine, 1987
- Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cellsNature, 1984